U.S. stock index futures climbed sharply in early trading after Washington and Tehran confirmed they had reached a preliminary peace agreement intended to end their conflict and reopen key Middle Eastern shipping routes. By 07:20 ET (11:20 GMT) equity futures were markedly higher, with S&P 500 Futures up 1.2%, Nasdaq 100 Futures rising 2.1% and Dow Jones Futures advancing 0.9%.
Technology and artificial intelligence-linked stocks were among the most pronounced movers in the premarket, with names tied to cryptocurrency also advancing as Bitcoin moved higher. Below are the largest premarket U.S. stock movers observed during the session.
- ON Semiconductor Corporation (NASDAQ:ON) - Shares climbed 4.8% after Citi placed the chipmaker on a 90-day catalyst watch while keeping a Neutral rating and a $120 price target, citing the potential for near-term developments to move the stock.
- Micron Technology Inc (NASDAQ:MU) - The memory chipmaker surged nearly 7.9% after several Wall Street firms significantly raised their price targets. TD Cowen increased its target to $1,500 from $660, while RBC lifted its target to $1,200 from $525, reflecting stronger-than-before optimism about the company's earnings outlook.
- Nebius Group NV (NASDAQ:NBIS) - Shares jumped 8.8% as investors positioned for the company’s coming inclusion in the Nasdaq-100 index. The stock is scheduled to join the benchmark before the open on June 22 after Nasdaq’s quarterly reconstitution, a change analysts expect will generate demand from passive funds that track the index.
- Strategy Inc (NASDAQ:MSTR) - The stock gained 5.3% as Bitcoin prices rose following reports of progress in U.S.-Iran negotiations. The company continued to attract investor interest for its Bitcoin acquisition strategy after recently using proceeds from a share sale to buy additional cryptocurrency holdings.
- Traws Pharma Inc (NASDAQ:TRAW) - The shares plunged 16.4% after the U.K.'s Medicines and Healthcare Products Regulatory Agency issued a negative review of the company’s Phase 2a influenza challenge study. That review forced the postponement of a key trial for Traws Pharma’s lead antiviral candidate, tivoxavir marboxil.
The early-session strength in technology and crypto-linked names was the dominant theme, pushing major futures contracts higher as market participants reacted to the diplomatic development and subsequent re-pricing of risk assets. The rise in Bitcoin accompanied gains for firms with direct exposure to cryptocurrency holdings.
Investors also reacted to firm-specific catalysts: analyst coverage moves for chipmakers, index reconstitution implications for small-cap listings, and regulatory developments that affected drug-development timelines. These distinct drivers combined to produce a market environment where optimism around easing geopolitical tensions and targeted corporate news lifted a swath of growth-oriented and crypto-connected equities, while regulatory setbacks hit speculative biotech names.
Market context note: The moves above reflect premarket trading conditions as of the stated time. Market dynamics can change rapidly during regular trading hours, and the premarket performance reported here relates to the specific developments and company announcements described.